Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Nanomedicine. 2012;7:2641-52. doi: 10.2147/IJN.S31133. Epub 2012 May 28.

Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells.

Author information

  • 1Department of Cell Biology, Second Military Medical University, Shanghai, People's Republic of China.

Abstract

In the rapid development of nanoscience and nanotechnology, many researchers have discovered that metal oxide nanoparticles have very useful pharmacological effects. Cuprous oxide nanoparticles (CONPs) can selectively induce apoptosis and suppress the proliferation of tumor cells, showing great potential as a clinical cancer therapy. Treatment with CONPs caused a G1/G0 cell cycle arrest in tumor cells. Furthermore, CONPs enclosed in vesicles entered, or were taken up by mitochondria, which damaged their membranes, thereby inducing apoptosis. CONPs can also produce reactive oxygen species (ROS) and initiate lipid peroxidation of the liposomal membrane, thereby regulating many signaling pathways and influencing the vital movements of cells. Our results demonstrate that CONPs have selective cytotoxicity towards tumor cells, and indicate that CONPs might be a potential nanomedicine for cancer therapy.

KEYWORDS:

apoptosis; cell cycle arrest; mitochondrion-targeted nanomaterials; nanomedicine; selective cytotoxicity

PMID:
22679374
[PubMed - indexed for MEDLINE]
PMCID:
PMC3368515
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk